WHO WE ARE
The Hellenic Association of Pharmaceutical Companies (SFEE) represents one of the most innovative, productive and extroverted industries of the national economy.
The aim of SFEE is to contribute to the establishment of a sustainable human-centered healthcare system that promotes public health and allows pharmaceutical companies to innovate, research, develop and offer new innovative and established treatment options for Greek patients, while contributing to the development of the national economy.
CONTRIBUTION
-
SOCIETY
Corporate Social Responsibility (CSR) is an essential element in all aspects of the strategy and day-to-day operations of SFEE. We are always on the side of society and patients, actively contributing to the support of our fellow citizens in need.
-
ECONOMY
By prioritizing continuous investment, promoting clinical research, introducing research know-how and creating new jobs, we contribute to the strengthening of business activity and the development of the national economy.
-
RESEARCH & DEVELOPMENT
We enhance the development of clinical research, by highlighting its role in improving the lives of patients and saving resources for the National Health System, as well as its essential contribution to the development of the national economy. Our goal is to make Greece a strong center for clinical studies with international impact.
THE GREEK PHARMACEUTICAL INDUSTRY IN FIGURES
€6,9 billion
3,1%
€1,9 billion
119,000
39%
LATEST NEWS
-
EOPE and SFEE Meeting: Initiatives and Coordination of Actions Focused on the Oncology Patient
HeSMO-SFEE Press Release
-
-
European pharmaceuticals key to strengthening EU competitiveness
EFPIA Press Release
-
A Pharmacovigilance awareness campaign entitled “Together for Safety – Did You Report It?”
under the auspices of the National Organization for Medicines (EOF)
PHARMACEUTICAL LEGISLATION
Search here for the pharmaceutical legislation in force and historical legislative references, as edited by the legal department of SFEE.
HELPDESK
Register a new request or follow the progress of your request.
TRANSPARENCY
-
AT CONFERENCES
-
IN CLINICAL STUDIES
-
Press Kit